Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Osteosarcoma × cabozantinib × Clear all

Phase

Phase 2 3 Phase 1 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Doxorubicin 3 Methotrexate 2 Cisplatin 2 merphos 1 cabozantinib 1 apatinib 1 Zoledronic Acid 1 X-Rays 1 Triptorelin Pamoate 1 Surgical Procedures, Operative 1 Platinum 1 Phantoms, Imaging 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Drug Therapy 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05691478 2026-03-19

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

National Cancer Institute (NCI)

Phase 2/3 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡